关于药监监测新进展的国际工作组:在药监测中推进方法和沟通
Dawn Cooper1, Robert W Platt2, Florence van Hunsel3
1Drug Safety Research Unit, Southampton, United Kingdom; The University of Portsmouth School of Pharmacy and Biomedical Science, Portsmouth, United Kingdom.
Clinical therapeutics
|January 17, 2024
概括
国际工作组 (IWG) 为更安全的药物推进药监方法. 他们正在开发对因果关系评估和数据源的范围审查,以改善药物安全监测.
科学领域:
- 药监和药物安全 药监和药物安全
- 监管科学 监管科学
- 公共卫生 公共卫生
背景情况:
- 新型疗法需要先进的药物监测方法来有效监测安全性.
- 减少临床试验时间表和更多地使用现实世界的证据,需要实时收集安全数据.
- 国际工作组 (IWG) 于2019年成立,以解决这些不断变化的需求.
研究的目的:
- 为药物和疫苗的安全和有效使用推进药监方法.
- 加强安全数据的检测,监测和分析.
- 通过改善药物安全监督来保护患者.
主要方法:
- 国际工作组确定了当前药物监测过程和方法研究的审查领域.
- 目前正在制作两个范围审查,以检查案例级因果关系评估和数据源的优势/局限性.
- 结果将通过同行评审的出版物,报告和会议演讲传播.
主要成果:
- 国际工作组正在积极审查药物监督中的病例级因果关系评估.
- 目前正在研究各种药监数据源的优点和局限性.
- 目前正在为监管机构,行业和学术界开发两个可访问的范围审查.
结论:
- 目前正在进行的范围审查与IWG推进药监督的使命保持一致.
- 这些审查将有助于改善医疗保健中关于药物安全的决策.
- 这篇文章概述了IWG在药物安全研究中的目标和当前活动.
相关概念视频
Pharmacovigilance
835
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
835
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Drug Administration and Therapy Phases: Overview
471
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
471


